CIK 0001795091 · <br>Emerging growth company
OS Therapies Inc
Sign in to watch- Ticker
- OSTX
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 825118368
- Phone
- 410-297-7793
- Business address
- 15825 SHADY GROVE ROAD, SUITE 135, ROCKVILLE, MD, 20850
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-10 | Clem Kerry M Chief Commercial Officer | Grant or award | +200,000 | 225,000 | ||
| 2026-11-10 | Clem Kerry M Chief Commercial Officer | Grant or award · Stock options (right to buy) | +700,000 | 700,000 | ||
| 2026-11-10 | Francis Knuettel II Chief Financial Officer | Grant or award | +250,000 | 250,000 | ||
| 2026-11-10 | Francis Knuettel II Chief Financial Officer | Grant or award · Stock options (right to buy) | +750,000 | 750,000 | ||
| 2026-10-22 | PETIT ROBERT See Remarks | Grant or award · Stock options (right to buy) | +200,000 | 200,000 | ||
| 2026-10-22 | McKean-Dieser Avril Suzette Director | Grant or award · Stock options (right to buy) | +300,000 | 300,000 | ||
| 2026-10-22 | Romness Paul A. President and CEO | Grant or award · Stock options (right to buy) | +900,000 | 900,000 | ||
| 2026-10-22 | Search Theodore F. Director | Grant or award · Stock options (right to buy) | +300,000 | 300,000 | ||
| 2026-10-22 | Ciccio John Director | Grant or award · Stock options (right to buy) | +300,000 | 300,000 | ||
| 2026-10-22 | Jarry Olivier Roger Director | Grant or award · Stock options (right to buy) | +300,000 | 300,000 | ||
| 2026-10-22 | EAGLE CRAIG Director | Grant or award · Stock options (right to buy) | +300,000 | 300,000 | ||
| 2026-10-22 | Francis Knuettel II Chief Financial Officer | Grant or award · Stock options (right to buy) | +300,000 | 300,000 | ||
| 2026-10-22 | Clem Kerry M Chief Commercial Officer | Grant or award · Stock options (right to buy) | +300,000 | 300,000 | ||
| 2026-01-22 | McKean-Dieser Avril Suzette Director | Grant or award · Stock options (right to buy) | +50,000 | 50,000 | ||
| 2026-01-22 | Search Theodore F. Director | Grant or award · Stock options (right to buy) | +50,000 | 50,000 | ||
| 2026-01-22 | Ciccio John Director | Grant or award · Stock options (right to buy) | +50,000 | 50,000 | ||
| 2026-01-22 | Acevedo Christopher P. Chief Financial Officer | Grant or award · Stock options (right to buy) | +100,000 | 100,000 | ||
| 2026-01-22 | PETIT ROBERT See Remarks | Grant or award · Stock options (right to buy) | +100,000 | 100,000 | ||
| 2026-01-22 | Romness Paul A. President and CEO | Grant or award · Stock options (right to buy) | +1,000,000 | 1,000,000 | ||
| 2026-01-22 | Jarry Olivier Roger Director | Grant or award · Stock options (right to buy) | +50,000 | 50,000 |
Page 1 of 4 · 67 trades